INGREZZA (valbenazine) capsules is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with tardive dyskinesia.
A free, virtual learning program on DRBA-induced movement disorders for HCPs
Sponsored and developed by Neurocine Biosciences, Inc.
To report an adverse event call: 877-641-3461